ANALYSIS OF AGREEMENT CONTAINING
Agency decision
Ask Donna
What actually matters in this document.
Text
ANALYSIS OF AGREEMENT CONTAINING
CONSENT ORDER TO AID PUBLIC COMMENT
In the Matter of Beretta Holding S.A.
File No. 261-0091
I.
Introduction
The Federal Trade Commission (“Commission”) has accepted for public comment,
subject to final approval, an Agreement Containing Consent Order (“Consent Agreement”) from
Beretta Holding S.A. (“Respondent”), a subsidiary of Upifra S.A. Pursuant to a Cooperation
Agreement dated May 2, 2026, Beretta may acquire up to 25% of the outstanding shares of
Sturm, Ruger & Company, Inc. (“Ruger”) for $44.80 per share, for a total transaction value of
approximately $167 million (“Proposed Transaction”). In addition to this consideration, Beretta
gained the right to “source” two members to be appointed and thereafter nominated to Ruger’s
Board of Directors. The Consent Agreement is designed to be a prophylactic safeguard against
any anticompetitive effects that may result from Beretta’s agreement with its direct competitor,
Ruger. The Commission alleges in its Complaint that the Proposed Transaction, if
consummated, would violate Section 8 of the Clayton Act, as amended, 15 U.S.C. § 19, and
Section 5 of the Federal Trade Commission Act, as amended, 15 U.S.C. § 45.
The Proposed Transaction raises Section 8 concerns. Specifically, Ruger’s obligation to
facilitate the appointment of two Beretta-sourced directors to Ruger’s board raises concerns that
Beretta could have access to Ruger’s competitively significant, nonpublic information and could
participate in, or have influence over, competitive decision-making at Ruger. The agreement
expressly provides that the parties could waive any restrictions on Beretta officers, employees,
agents, representatives, or directors from serving as Ruger directors. Under Section 8 of the
Clayton Act, it is illegal for directors and officers to serve, whether directly or indirectly, on the
boards of competitors (subject to limited safe harbors), as would occur here because of Beretta’s
right to source two of its designees to the board of its competitor, Ruger.
The Consent Agreement is designed to remedy allegations in the Commission’s
Complaint that Beretta’s proposed acquisition would provide the right to source two Beretta
designees to appoint and nominate for a seat on the Ruger Board of Directors. This would result
in an illegal interlocking directorate in violation of Section 8 of the Clayton Act, 15 U.S.C. § 19,
and an unfair method of competition in violation of Section 5 of the Federal Trade Commission
Act, 15 U.S.C. § 45 due to the potential exchange of confidential, competitively sensitive
information.
The proposed settlement provides significant relief for this concern. The Consent
Agreement and proposed Decision and Order (“D&O”) prohibit Beretta from appointing,
sourcing, nominating, or occupying any director position on Ruger’s Board unless that director is
independent of Beretta.
The proposed D&O imposes effective relief, while continuing to set important
Commission precedent on the application of Section 8 of the Clayton Act and Section 5 of the
FTC Act. By restricting future opportunities for the parties to engage in conduct that would
1
result in Section 8 violations, the proposed D&O signals the antitrust risks of excessive influence
and anticompetitive information exchange.
The Commission has placed the Consent Agreement on the public record for thirty days
to solicit comments from interested persons. Comments received during this period will become
part of the public record. After thirty days, the Commission will review the comments received
and decide whether it should withdraw, modify, or make the proposed Order final.
II.
The Respondent
Respondent Beretta is the largest firearms manufacturer in the world. Beretta’s
headquarters are in Luxembourg, and its primary corporate offices in the United States are in
Accokeek, Maryland.
III.
The Cooperation Agreement
On May 2, 2026, Beretta and Ruger entered into a Cooperation Agreement, under which
Beretta seeks to acquire up to 25% of Ruger’s outstanding shares at $44.80 per share, for a total
transaction value of approximately $167 million. Beretta already owns 9.96% of Ruger’s shares.
The Proposed Transaction would make Beretta one of Ruger’s largest shareholders.
Additionally, the Ruger Board of Directors “shall” “take such actions as are necessary to appoint
two directors sourced by Beretta Holding” and renominate the Beretta directors at the 2027 and
2028 annual board meetings. The Cooperation Agreement refers to these appointments as the
“Beretta Holding Director Appointments” and the directors are the “Beretta Holding Directors.”
The Commission’s Complaint alleges that the Proposed Transaction, as structured, would
violate Section 8 of the Clayton Act, 15 U.S.C. § 19, as an illegal interlocking directorate, and
that the Proposed Transaction also constitutes an unfair method of competition in violation of
Section 5 of the Federal Trade Commission Act, 15 U.S.C. § 45 due to the risk of the exchange
of competitively sensitive, nonpublic information.
IV.
Line of Commerce
The production and sale of firearms, including pistols, shotguns, and rifles, are the
relevant lines of commerce. Firearms serve a wide range of uses in the United States, including
personal protection, sport shooting, hunting, law enforcement, and collecting. Buyers of
firearms typically cannot substitute other products for these purposes without significant
compromises in functionality.
The firearms market is characterized by a large set of established manufacturers. Major
competitors include companies such as Smith & Wesson, SIG Sauer, Glock, Springfield Armory,
and Browning Arms Company, among others, with each offering broad portfolios of firearms
across price points and performance categories. Beretta is recognized as a premium, globally
established manufacturer, with particular historical strength in shotguns and semiautomatic
pistols, while Ruger is known as a purely U.S. manufacturer with significant share in rifles and
handguns. Both companies sell to overlapping customer groups, including recreational shooters,
hunters, sports shooters, and law‑enforcement agencies.
2
V.
Effects of the Agreement
The Commission’s Complaint addresses the theory of harm that interlocking directorates
can present opportunities or temptations for anticompetitive conduct. Beretta’s placement of a
director or officer on Ruger’s board—in violation of Section 8 of the Clayton Act—would make
Beretta a direct participant in Ruger’s corporate governance. This interlocking directorate
arrangement would provide Beretta with the ability to sway or influence Ruger’s competitive
decision-making and to access Ruger’s competitively sensitive information. As an interlocked
director or officer, Beretta’s representative would have the opportunity to communicate directly
within Ruger’s highest levels of leadership and could discuss confidential business information
or direct or otherwise influence Ruger’s competitive actions or strategies. Knowledge gained via
this prohibited interlocking relationship could also influence Beretta’s own competitive decisions
or development of new businesses involved in the production and sale of firearms.
VI.
The Proposed Order
The proposed Order imposes several obligations designed to address the competitive
concerns arising from Beretta’s proposed acquisition of voting securities of Ruger and the
potential for interlocking directorates or improper access to competitively sensitive information.
First, the proposed Order limits Beretta’s ability to place representatives or agents on
Ruger’s board of directors. Beretta may not, directly or indirectly, including through its parent,
appoint, nominate, or otherwise cause any person to serve on Ruger’s board unless that person
qualifies as independent from Beretta, i.e., an “Independent Director” as defined in the Order.
The proposed Order defines an Independent Director as a person who is not affiliated with
Beretta, Upifra, or their controlled entities; has not recently served as an employee, officer,
director, representative, or agent of a relevant person; has not recently received compensation
from a relevant person; and does not have a material relationship that would reasonably be
expected to impair the objectivity of the director’s judgment when serving on Ruger’s board.
Second, the proposed Order requires Beretta to provide the Commission with advance
written notice at least 15 days before appointing, designating, nominating, electing, or otherwise
causing any person to become a member of Ruger’s board of directors.
Third, the proposed Order restricts Beretta’s relationships with any Independent Director
it nominates to Ruger’s board. Beretta may not, directly or indirectly, including through its
parent, hire or enter into any financial or other relationship with such Independent Director that
would involve violating the Independent Director’s fiduciary duties or involve the exchange of
Ruger’s nonpublic information with Beretta, Upifra, or their affiliates. These restrictions remain
in place until one year after the Independent Director has ceased serving on Ruger’s board.
Fourth, the proposed Order prohibits Beretta from directly or indirectly seeking,
receiving, or attempting to receive Ruger’s nonpublic information from any Independent
Director appointed pursuant to the Order. The Order defines nonpublic information broadly to
include information not in the public domain, such as customer lists, price lists, strategic plans,
contracts, expansion projects, cost information, marketing methods, competitively sensitive data
or information, and other nonpublic information.
3
Fifth, the proposed Order requires Beretta to distribute the Order to each of its respective
board members, officers, and directors, and to design, maintain, and operate an antitrust
compliance program.
***
The purpose of this analysis is to facilitate public comment on the Consent Agreement
and proposed Order to aid the Commission in determining whether it should make the proposed
Order final. This analysis is not an official interpretation of the proposed Order and does not
modify its terms in any way.
4
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.